Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-09-16 00:00:00 ET · period of report 2025-09-12 · accession 0001193125-25-205260 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-09-16 | 2025-09-12+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | S - Sale+OE | $117.08 | -62.9K | 7,229 | -90% | -$7.36M |
| DMT | 2025-09-16 | 2025-09-12+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $8.02 | +62.9K | 26.9K | New | +$504.3K |
| DMT | 2025-09-16 | 2025-09-12+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $0.00 | -62.9K | 480.8K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-15 | S | D | 15,254 | $117.37 | 7,229 | D | — | — | (F5) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $116.70 and $118.44. |
| 2 | Common | Common Stock | 2025-09-15 | M | A | 15,254 | $8.02 | 22,483 | D | — | — | |
| 3 | Common | Common Stock | 2025-09-12 | S | D | 27,907 | $118.96 | 7,229 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $117.81 and $122.54. |
| 4 | Common | Common Stock | 2025-09-12 | M | A | 27,907 | $8.02 | 35,136 | D | — | — | |
| 5 | Common | Common Stock | 2025-09-16 | S | D | 19,719 | $114.19 | 7,229 | D | — | — | (F6) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $113.01 and $116.10. |
| 6 | Common | Common Stock | 2025-09-16 | M | A | 19,719 | $8.02 | 26,948 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2025-09-16 | M | D | 19,719 | $0.00 | 461,120 | D | $114.19 · 2017-05-27 to 2026-05-27 | 19,719 Common Stock | |
| 8 | Derivative | Stock Option (Right to Buy) | 2025-09-12 | M | D | 27,907 | $0.00 | 496,093 | D | $118.96 · 2017-05-27 to 2026-05-27 | 27,907 Common Stock | |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-09-15 | M | D | 15,254 | $0.00 | 480,839 | D | $117.37 · 2017-05-27 to 2026-05-27 | 15,254 Common Stock |